However, exploring multiple aspects, such as the cell cycle, ERβ isoforms, and expression rates of BC and endothelial cell lines, as well as exposure to serum E2, is necessary to adapt our current insights to the clinical situation. The gene discussed is ESR2; the disease is breast cancer.